<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F214B81B-2F0A-4723-B5D3-33813C4B47E5"><gtr:id>F214B81B-2F0A-4723-B5D3-33813C4B47E5</gtr:id><gtr:name>John Radcliffe Hospital</gtr:name><gtr:address><gtr:line1>Headley Way</gtr:line1><gtr:line2>Headington</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 9DU</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1EEF82D6-26FA-45CD-8BEE-37EC5C251CF2"><gtr:id>1EEF82D6-26FA-45CD-8BEE-37EC5C251CF2</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Wilson</gtr:otherNames><gtr:surname>Meade</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701113"><gtr:id>02A6D084-8EDA-420F-8F69-63BC6FB45393</gtr:id><gtr:title>Strategic Appointment - Professorship</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701113</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>169360</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>John Radcliffe Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Neurology</gtr:department><gtr:description>Low dose aspirin and incidence and mortality of cancer</gtr:description><gtr:id>527BFDC6-7DAE-483B-87C5-01E5BBECA5FE</gtr:id><gtr:impact>Please see Publications.

17.04.2017. This collaboration ended at least five years ago.</gtr:impact><gtr:outcomeId>neTgcSsgnD2-1</gtr:outcomeId><gtr:partnerContribution>Coordination of data from several randomised controlled trials (RCTs) of aspirin.</gtr:partnerContribution><gtr:piContribution>Supplied data for overview and took part in writing papers.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media press releases &amp; article for lay readership</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ADFE92D8-9D67-4CF1-BA13-739446A236B5</gtr:id><gtr:impact>Interview for BBC programmes

Some increased awareness of importance of preventive measures in people at high risk who are having/recently had respiratory infections.</gtr:impact><gtr:outcomeId>18574E61EE5</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Use of low-dose aspirin</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>470. T. Meade. Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents. Handb Exp Pharmacol 2012; (210):565-605.</gtr:guidelineTitle><gtr:id>46747577-2CB0-4D06-B5E8-621EF9C36D16</gtr:id><gtr:outcomeId>ZwjT6fncHd3</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7B4156B4-E317-4F0C-83C7-20375B3C8992</gtr:id><gtr:title>Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England.</gtr:title><gtr:parentPublicationTitle>Population health metrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69e937cdd40fd874b9ff14424017527e"><gtr:id>69e937cdd40fd874b9ff14424017527e</gtr:id><gtr:otherNames>Nacul LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1478-7954</gtr:issn><gtr:outcomeId>2CA0A64AF0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D02E350-C333-4E42-BDCA-5E26C5D86385</gtr:id><gtr:title>Skinfold thickness, body mass index, and fatal coronary heart disease: 30 year follow up of the Northwick Park heart study.</gtr:title><gtr:parentPublicationTitle>Journal of epidemiology and community health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/777f83df34e1859c83cdf51578caf9d5"><gtr:id>777f83df34e1859c83cdf51578caf9d5</gtr:id><gtr:otherNames>Kim J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0143-005X</gtr:issn><gtr:outcomeId>610F22412F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E48F7A-2A99-44F6-8EBA-0815C7811461</gtr:id><gtr:title>Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b364850b87805d60860a5540d559a0b7"><gtr:id>b364850b87805d60860a5540d559a0b7</gtr:id><gtr:otherNames>Clayton TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>5BE7B28E8F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD83FEA-FE3C-4FC5-9A18-F0AA167330A4</gtr:id><gtr:title>Distinguishing between those dying suddenly or not suddenly from coronary heart disease: long-term prospective results from the Northwick Park Heart Study.</gtr:title><gtr:parentPublicationTitle>Open heart</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a92653135fe5a03e7401e59ebb3db22"><gtr:id>4a92653135fe5a03e7401e59ebb3db22</gtr:id><gtr:otherNames>Meade T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2053-3624</gtr:issn><gtr:outcomeId>58f5e31aaf46a8.50999482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DD4CE21-CB67-4E86-81B2-EFDB3CAC4845</gtr:id><gtr:title>Insight into the nature of the CRP-coronary event association using Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf19195b6da69f15f5912aea3dcb019e"><gtr:id>cf19195b6da69f15f5912aea3dcb019e</gtr:id><gtr:otherNames>Casas JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>79F333F352D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A69493BD-53F3-4021-BF21-B682C5B883E7</gtr:id><gtr:title>The Northwick Park Heart Studies: contrasts between the two factor VII assays used.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6279daf6971c2073e967749e37107936"><gtr:id>6279daf6971c2073e967749e37107936</gtr:id><gtr:otherNames>Meade TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12514_24_22235852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C45AD410-2439-4D43-AD67-B0A9E0BC38D5</gtr:id><gtr:title>An Aspirin a day. The Wonder Drug that could save your life</gtr:title><gtr:parentPublicationTitle>Michael O'Mara Books Limited</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5614f6f99828f441e441586b17b30eee"><gtr:id>5614f6f99828f441e441586b17b30eee</gtr:id><gtr:otherNames>Dr. Keith Souter. Foreword by Professor Tom Meade</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-1-84317-632-9</gtr:isbn><gtr:outcomeId>kag1jWVM473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDAAB591-0010-435C-ADB8-2DC1D88F5D71</gtr:id><gtr:title>The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01a50d6dd425eaa7a6e921ca2fc8a17d"><gtr:id>01a50d6dd425eaa7a6e921ca2fc8a17d</gtr:id><gtr:otherNames>Cholesterol Treatment Trialists' (CTT) Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12514_24_22607822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1ECA2DF-BF9E-4D1C-ACF5-F24F0A63FC58</gtr:id><gtr:title>Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c34e94bd25d0c4d84818d65e5b6d975"><gtr:id>2c34e94bd25d0c4d84818d65e5b6d975</gtr:id><gtr:otherNames>Bartlett JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>PN4NQqPT1vG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3BB767-5101-452C-BCD4-AB2177A07470</gtr:id><gtr:title>Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56ecc6eb359e37f1f832c733561cbe61"><gtr:id>56ecc6eb359e37f1f832c733561cbe61</gtr:id><gtr:otherNames>Rothwell PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12514_24_22440947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BA0D3A2-D8CF-42AD-AE17-C87CAF9559BC</gtr:id><gtr:title>Primary prevention of ischaemic cardiovascular disorders with antiplatelet agents.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a92653135fe5a03e7401e59ebb3db22"><gtr:id>4a92653135fe5a03e7401e59ebb3db22</gtr:id><gtr:otherNames>Meade T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>pm_12514_24_22918747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D56DA8B-FFC5-415F-964E-DF9BFBF53F39</gtr:id><gtr:title>Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9585e9537d416647e725c9daf0b94f44"><gtr:id>9585e9537d416647e725c9daf0b94f44</gtr:id><gtr:otherNames>De Stavola BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>48A46C87F08</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91542DEB-2B83-44D7-8F4F-17265030F6D1</gtr:id><gtr:title>Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bb74d78a484c2052fd56771b60d42bd"><gtr:id>9bb74d78a484c2052fd56771b60d42bd</gtr:id><gtr:otherNames>dos Santos Silva I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>oNp3E1JNbzr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE2D9E42-150E-49E8-BB8E-6D51EFACBA6F</gtr:id><gtr:title>Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56ecc6eb359e37f1f832c733561cbe61"><gtr:id>56ecc6eb359e37f1f832c733561cbe61</gtr:id><gtr:otherNames>Rothwell PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>eA78sjr8vX8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F6C5CDE-1D5D-4B0E-AF53-6FBE080A1FDA</gtr:id><gtr:title>Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56ecc6eb359e37f1f832c733561cbe61"><gtr:id>56ecc6eb359e37f1f832c733561cbe61</gtr:id><gtr:otherNames>Rothwell PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>XcRbLk7vLRM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D2A8FCB-4118-47E8-92F7-AB40AB5CFCF0</gtr:id><gtr:title>Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36fd39f77e77f16a1456bb24adda4813"><gtr:id>36fd39f77e77f16a1456bb24adda4813</gtr:id><gtr:otherNames>Pizzi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>ApH1NeshagH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B117FB-58BF-4B5D-981F-0869128A2FC9</gtr:id><gtr:title>Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8685fd86042ee73c7d791536116d7b83"><gtr:id>8685fd86042ee73c7d791536116d7b83</gtr:id><gtr:otherNames>Rudnicka AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>s3zQJiVUA1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E977EB0-26E0-432E-B8EF-4D858E55A18D</gtr:id><gtr:title>Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/422e300a7c5463cf3187c6b8452775db"><gtr:id>422e300a7c5463cf3187c6b8452775db</gtr:id><gtr:otherNames>Antithrombotic Trialists' (ATT) Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>m6pVkuzVKFU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>991651B4-99F2-40F1-843B-3F6ACF228B56</gtr:id><gtr:title>The effect of aspirin on cancer mortality</gtr:title><gtr:parentPublicationTitle>THROMBOSIS RESEARCH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/843d71e44ceecaec3e63b1cae2d70206"><gtr:id>843d71e44ceecaec3e63b1cae2d70206</gtr:id><gtr:otherNames>Meade T.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0049-3848</gtr:issn><gtr:outcomeId>cLXGNM4ZGiN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B89D77C5-7F0E-493F-B761-04D6295E79A5</gtr:id><gtr:title>The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC women's health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/559eb1ab251056cbb86b615b24945f32"><gtr:id>559eb1ab251056cbb86b615b24945f32</gtr:id><gtr:otherNames>Vickers MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1472-6874</gtr:issn><gtr:outcomeId>A03660A0A18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC14F36-1B14-440A-A3E1-B6417CFF25FA</gtr:id><gtr:title>Review: Plasma renin and the incidence of cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Journal of the renin-angiotensin-aldosterone system : JRAAS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a92653135fe5a03e7401e59ebb3db22"><gtr:id>4a92653135fe5a03e7401e59ebb3db22</gtr:id><gtr:otherNames>Meade T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-3203</gtr:issn><gtr:outcomeId>PwTrD9Sq2Xn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97777F43-C2AA-4F6E-B3BD-88F7203755D3</gtr:id><gtr:title>Health related quality of life after combined hormone replacement therapy: randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87114031886ccb9eaa88b7d6f7e9280"><gtr:id>d87114031886ccb9eaa88b7d6f7e9280</gtr:id><gtr:otherNames>Welton AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>F1B9D14E235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AD1BC3C-E650-40F5-8601-4767D5307F60</gtr:id><gtr:title>Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6279daf6971c2073e967749e37107936"><gtr:id>6279daf6971c2073e967749e37107936</gtr:id><gtr:otherNames>Meade TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>2D0A7B2EFD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38CEBFEA-4CC5-4639-A17F-2B3CF59F432B</gtr:id><gtr:title>Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8685fd86042ee73c7d791536116d7b83"><gtr:id>8685fd86042ee73c7d791536116d7b83</gtr:id><gtr:otherNames>Rudnicka AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>1D8BB64B64C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08375B9A-2F21-4B29-9E47-27A4B2B0F5B0</gtr:id><gtr:title>The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cd7748befd4e2727df7aa6f74dba1b8"><gtr:id>5cd7748befd4e2727df7aa6f74dba1b8</gtr:id><gtr:otherNames>Becker RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>0444BB600FC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E2E2BB0-20B5-4DD6-9073-EB1578D7B10F</gtr:id><gtr:title>Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>tyXhPfkZyma</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701113</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>